Alto Neuroscience Ownership | Who Owns Alto Neuroscience?
Alto Neuroscience Ownership Summary
Alto Neuroscience is owned by 7.20% institutional investors, 6.44% insiders, and 86.36% retail investors. Alpha wave global, lp is the largest institutional shareholder, holding 13.70% of ANRO shares.
ANRO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alto Neuroscience | 7.20% | 6.44% | 86.36% |
| Sector | Healthcare Stocks | 232.63% | 10.66% | -143.29% |
| Industry | Biotech Stocks | 382.12% | 10.42% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Alpha wave global, lp | 3.71M | 13.70% | $14.91M |
| Armistice capital | 1.64M | 6.04% | $6.58M |
| Vanguard group | 1.37M | 5.04% | $24.31M |
| Point72 asset management | 1.33M | 4.92% | $5.36M |
| Franklin resources | 1.12M | 4.13% | $19.93M |
| Vestal point capital, lp | 950.00K | 3.51% | $3.82M |
| Marshall wace, llp | 825.23K | 3.05% | $3.32M |
| 72 investment | 667.78K | 2.47% | $2.68M |
| Blackrock funding, inc. /de | 607.87K | 2.24% | $10.82M |
| Alkeon capital management | 477.10K | 1.76% | $1.92M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 72 investment | 667.78K | 3.95% | $2.68M |
| Peapod lane capital | 253.99K | 3.85% | $4.52M |
| Alpha wave global, lp | 3.71M | 1.51% | $14.91M |
| Awm investment company | 225.00K | 0.39% | $4.00M |
| Almitas capital | 195.15K | 0.18% | $784.48K |
| Vestal point capital, lp | 950.00K | 0.17% | $3.82M |
| Advisorshares investments | 44.08K | 0.13% | $784.57K |
| Integral health asset management | 400.00K | 0.11% | $1.61M |
| Armistice capital | 1.64M | 0.10% | $6.58M |
| Ikarian capital | 110.00K | 0.04% | $442.20K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 1.37M | 0.00% | 260.44K |
| Blackrock funding, inc. /de | 607.87K | 0.00% | 240.00K |
| Northwestern mutual wealth management | 212.67K | 0.01% | 211.22K |
| Perceptive advisors | 155.37K | 0.02% | 155.37K |
| Jane street group | 194.04K | 0.00% | 145.68K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Woodline partners lp | - | - | -359.87K |
| Ubs group | 18.49K | 0.00% | -120.54K |
| Charles schwab investment management | - | - | -115.26K |
| Marshall wace, llp | 825.23K | 0.00% | -112.18K |
| Td asset management | - | - | -110.79K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Perceptive advisors | 155.37K | 0.02% | 155.37K | $624.57K |
| Advisorshares investments | 44.08K | 0.13% | 44.08K | $784.57K |
| Dimensional fund advisors lp | 31.18K | 0.00% | 31.18K | $554.93K |
| Alps advisors | 25.50K | 0.00% | 25.50K | $453.99K |
| Xtx topco | 15.75K | 0.00% | 15.75K | $63.30K |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -126.00 |
| Sterling capital management | -161.00 |
| Clearstead advisors | -178.00 |
| Nelson, van denburg & campbell wealth management group | -249.00 |
| Wells fargo & company/mn | -351.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 18 | -76.62% | 1,951,777 | -88.35% | 7 | 0.19% | 10 | -60.00% | 4 | -85.19% |
| Sep 30, 2025 | 17 | -78.48% | 1,494,416 | -91.36% | 5 | 0.14% | 9 | -78.57% | 5 | -76.19% |
| Jun 30, 2025 | 79 | -7.06% | 17,296,404 | -16.08% | 63 | 1.10% | 42 | 7.69% | 21 | -16.00% |
| Mar 31, 2025 | 86 | 7.50% | 20,845,493 | -6.06% | 77 | 1.14% | 39 | -23.53% | 26 | 100.00% |
| Dec 31, 2024 | 81 | -5.81% | 22,530,140 | -1.78% | 83 | 1.15% | 52 | -21.21% | 13 | 44.44% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $38.75K |
| Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $18.25K |
| Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $133.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q3 | 3 | - |
ANRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools